Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity |
| |
| Authors: | Alexander L. Ruchelman Hon-Wah Man Weihong Zhang Roger Chen Lori Capone Jian Kang Anastasia Parton Laura Corral Peter H. Schafer Darius Babusis Mehran F. Moghaddam Yang Tang Michael A. Shirley George W. Muller |
| |
| Affiliation: | 1. Drug Discovery Department, Celgene Corporation, 86 Morris Avenue, Summit, NJ 07901, United States;2. Department of DMPK, Celgene Signal Research, 4550 Towne Centre Court, San Diego, CA 92121, United States |
| |
| Abstract: | A series of analogs of the immunomodulary drugs lenalidomide (1) and pomalidomide (2), in which the amino group is replaced with various isosteres, was prepared and assayed for immunomodulatory activity and activity against cancer cell lines. The 4-methyl and 4-chloro analogs 4 and 15, respectively, displayed potent inhibition of tumor necrosis factor-α (TNF-α) in LPS-stimulated hPBMC, potent stimulation of IL-2 in a human T cell co-stimulation assay, and anti-proliferative activity against the Namalwa lymphoma cell line. Both of these analogs displayed oral bioavailability in rat. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
